Obermatt
See Similar Stocks →

Sight Sciences

NSQ:SGHT · US82657M1053
Health Care Equipment & SuppliesSmall

360

44
Profit price64
Owner Earnings Yield1
Dividend Yield1
Price/Sales45
EV / Gross Profit58
Price/Book16
Return on Capital39
Cash Return on Capital18
Return on Equity34
EBIT Margin29
Gross Profitability82
Accruals71
Owner Earnings Margin25
Sales growth61
Profit growth23
Reinvestment99
Price momentum62
Debt load40
Refinancing30
Debt Payback1
Liquidity34
Analyst ratings36
Opinion Changes50
Price Target Upside67
Market mood13
Value Creation4/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Sight Sciences doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
TypePublic Company
ExchangeNASDAQGS
Founded2010
Employees218
Websitesightsciences.com
ISINUS82657M1053
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
SurgeryBiomedical EngineeringInjection MoldingOphthalmologyWearablesHealth CareHealth DiagnosticsMedical DeviceWellness

Description

Sight Sciences, Inc. (Sight Sciences) operates as an ophthalmic medical device company. The company focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company's…

Analysis

Middle-of-the-road

Sight Sciences, Inc. sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

Valuation data is not available for this company.

Growth is moderate; the safety picture is stretched. The company scores 4/20 on our value-creation score: not creating value.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
4
2023202420252026

All-time high

65

Jan 2025

All-time low

1

Mar 2026

Average rank

28

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
45
67
73
23
Price/Earnings
78
96
96
22
Price/Book
16
80
96
76
Dividend Yield
1
1
1
1
Value (overall)
32
69
78
47

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Sight Sciences with its peers
Glaukos
NYQ:GKOS
31
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
Enovis
NYQ:ENOV
40
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
Inspire Medical Systems
NYQ:INSP
66
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
AngioDynamics
NSQ:ANGO
57
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
SANUWAVE Health
NMQ:SNWV
33
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
SI-BONE
NMQ:SIBN
33
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →